> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ‘Mixed Reality Device’ CGMP Inspection Success
- URL: https://www.fdaweb.com/mixed-reality-device-cgmp-inspection-success/
- Published: 2023-11-28T12:00:00.000Z
- Updated: 2026-09-14T14:17:03.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5155873

Researchers say a pilot program using a mixed reality device with a collaborative text messaging system allowed multiple national regulatory authorities, including FDA, to perform a regulatory inspection of a good manufacturing practice (GMP) facility simultaneously, while still following their respective internal procedures. Writing in *Therapeutic Innovation & Regulatory Science*, the researchers say remote inspections can reduce the number of on-site inspections any company may have to host, by effectively allowing multiple regulatory agencies to inspect simultaneously.

“The use of a mixed reality device and Microsoft Teams platform to perform a GMP inspection including multiple national regulatory authorities is feasible,” the article concludes. “Further testing of improved versions of the technology will provide a more seamless experience for inspectors on-site and participating virtually.”

In the pilot mock inspection at a U.S. drug manufacturing facility conducted by two former FDA investigators, with participation by representatives from several other regulatory authorities, the representatives were able to interact directly with the on-site inspectors, one of whom was wearing a virtual reality headset. The representatives were able to ask specific inspection questions, evaluate the facility, and review requested documents, the report says.